The National Association of Pharmacy Regulatory Authorities (NAPRA) has become aware of various organizations and groups offering education sessions related to the NAPRA draft documents Model Document for Pharmacy Regulatory Authority Use – Non-sterile Compounding Standards and Model Document for Pharmacy Regulatory Authority Use – Sterile Compounding Standards.

These draft documents were released for public consultation from January to March 2026 as NAPRA sought additional external input before finalization. As these materials remain in draft form and are subject to change, education on their content should not be delivered at this stage. Because NAPRA is developing these model documents for pharmacy regulatory authorities (PRAs) across Canada, there may be differences in how each province or territory implements final standards for their province/territory.

NAPRA expects that education on the proposed compounding documents be postponed until they are finalized. However, recognizing that some educational sessions may still proceed, NAPRA requires that any such activities include clear disclaimers that they are offering education on proposed documents that are subject to change and may not be implemented the same way in every province/territory.

NAPRA advises pharmacy professionals who encounter promotional materials or attend presentations related to the draft documents to keep the following in mind:

• The draft documents are still subject to change – the final documents will likely be different from the draft documents.
• Even once finalized, the NAPRA documents are only a model/template for the PRAs – the PRAs use the NAPRA documents as a foundation for the standards in their province/territory – which will also likely be different from the draft documents.
• Not everything they see in the draft documents will end up being a final requirement, so individuals should be cautious about the information provided and should not take any action related to the draft documents. They should instead wait to hear directly from the PRA in their province/territory about the compounding standards in their province or territory.
• Finally, there will be many steps and ample time between the publication of the final NAPRA documents and when the PRAs determine and implement the standards specific to their province/territory in which pharmacy professionals can learn about any new requirements for their jurisdiction and make any required changes.